MEDP
Overvalued by 4.1% based on the discounted cash flow analysis.
Market cap | $12.12 Billion |
---|---|
Enterprise Value | $11.71 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $9.82 |
Beta | 1.3 |
Outstanding Shares | 30,983,399 |
Avg 30 Day Volume | 255,654 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 38.8 |
---|---|
PEG | 95.15 |
Price to Sales | 6.36 |
Price to Book Ratio | 19.08 |
Enterprise Value to Revenue | 5.97 |
Enterprise Value to EBIT | 33.01 |
Enterprise Value to Net Income | 37 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data